State of the Art Ovarian Cancer Conference 2016

State of the Art Ovarian Cancer Conference is organized by Memorial Sloan Kettering Cancer Center and would be held on Oct 6, 2016 at Zuckerman Research Center, New York, United States of America.

The target audience includes all clinicians, scientists and advocates interested in women’s health, and in optimizing the prevention, screening and treatment for ovarian cancer. Clinicians including OB/GYNs, surgical/medical/gynecologic oncologists, primary care physicians, physician assistants, nurse practitioners, nurses, fellows and residents and other healthcare professionals are welcome.

Advances in women’s health research provide important opportunities to enhance the screening and prevention of ovarian cancer. New modalities in the treatment of the disease provide the ability to individualize therapy, accomplish best clinical outcomes, and optimize the patient experience. This CME Conference has been approved with a maximum of 7.25 AMA PRA Category 1 Credits.

Conference Objectives are :
• Discuss new genetic panel testing and its implication, results of recent ovarian cancer screening trial, and strategies for ovarian cancer risk-reduction.
• Present new algorithms for imaging and surgical case selection.
• Evaluate emerging opportunities in clinical trial options, individualized treatment, and enhanced patient experience.